About Cori Cather, PhD

Dr. Corinne Cather is an Assistant Professor of Psychology at Harvard Medical School and the Director of Psychology Services for the Schizophrenia Clinical and Research Program at the Massachusetts General Hospital Schizophrenia Program in Boston.  Dr. Cather earned her undergraduate degree in biopsychology at Hamilton College in Clinton, NY and her doctorate in clinical psychology from Rutgers University where she received specialized training in cognitive behavioral therapy (CBT) and behavioral medicine.  She completed an internship at the University of Medicine and Dentistry of New Jersey and joined the Schizophrenia Clinical and Research Program as a post-doctoral fellow in 1999.

Clinical interests

She has extensive experience as a clinician-researcher with first episode/early psychosis as well as with chronic schizophrenia and she has developed an international reputation as one of the few practitioners in the US to study and train in cognitive behavioral therapy in schizophrenia. She served as a consultant on the NIMH RAISE project designed to disseminate training in state-of-the-art multi-component first episode treatment and was responsible for developing the individual and family intervention manuals around preventing and responding to weight gain and smoking cessation for this project.

Departments, Centers, & Programs:



Psychiatry-Outpatient Services
15 Parkman Street
Boston, MA 02114-3117
Fax: 617-726-5641

Medical Education

  • PhD, Rutgers University

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Cather's research interests include the development and implementation of CBT to residual symptoms, medication adherence, and substance use disorders in individuals with schizophrenia spectrum disorders. Her group was the lead site for the first randomized controlled trial of CBT in schizophrenia published in the United States. She has authored several manualized treatment protocols for increasing readiness to quit smoking, smoking cessation, and smoking relapse prevention that are based on cognitive-behavioral and motivational enhancement principles for smokers with severe mental illness diagnoses and has trained interventionists across the US to deliver these treatments with high fidelity to the model.